Infectious Contributions to Parkinson's Disease Dynamics

Parkinson’s disease (PD) is increasingly recognised as not merely a neurodegenerative disorder of dopaminergic neurons but one in which peripheral infections and immune responses play a pivotal role in disease initiation and progression. Accumulating evidence suggests that bacterial and viral pathogens can induce local inflammation, promote misfolding and aggregation of α-synuclein in peripheral nerves or enteric tissues, and trigger a cascade of neuroinflammatory events that culminate in the loss of substantia nigra neurons. Gut–brain axis perturbations, systemic cytokine elevations and activation of microglia are now understood as central mechanisms by which infectious insults amplify neurodegenerative processes. Such dynamics may help to explain the heterogeneity of clinical presentations, variable progression rates and differential response to therapies. The global significance of these findings lies in the potential for infection-targeted interventions—ranging from antimicrobial treatment to immune modulation—to complement traditional neuroprotective strategies and arrest or even prevent the emergence of PD in at-risk populations.

Research from Nature Portfolio

Recent studies have demonstrated that exposure of α-synuclein to bacterial endotoxin generates a structurally distinct, self-renewing fibril strain that reproducibly induces synucleinopathy in animal models. This work reveals a direct link between bacterial components and the conformational diversity of α-synuclein aggregates, offering a mechanistic basis for how environmental pathogens may drive specific patterns of protein misfolding in Parkinson-like disorders. The identification of lipopolysaccharide-induced fibril strains underscores the importance of peripheral immune signals in shaping central proteinopathy and supports the strain hypothesis as a unifying concept in synucleinopathies.

Infectious Contributions to Parkinson's Disease Dynamics publication trend

The graph below shows the total number of articles in infectious contributions to parkinson's disease dynamics across all publications each year (not limited to Nature Index journals).

Technical terms

α-Synuclein: A neuronal protein prone to misfolding and aggregation, central to Lewy body formation and synucleinopathy.

Dopaminergic neurons: Nerve cells in the substantia nigra that produce dopamine, whose loss leads to the motor symptoms of PD.

Neuroinflammation: Activation of immune cells within the central nervous system, notably microglia and astrocytes, in response to injury or infection.

Synucleinopathy: A class of neurodegenerative diseases characterised by pathological accumulation of α-synuclein aggregates.

Innate immune response: The immediate, non-specific defence mechanism involving cells such as neutrophils and macrophages activated by pathogen-associated molecular patterns.

References

1. SARS-CoV-2 infection causes dopaminergic neuron senescence. Cell Stem Cell (2024).
2. Urinary tract infections trigger synucleinopathy via the innate immune response. Acta Neuropathologica (2023).
3. Inflammation, Infectious Triggers, and Parkinson's Disease. Frontiers in Neurology (2019).
4. Infectious Etiologies of Parkinsonism: Pathomechanisms and Clinical Implications. Frontiers in Neurology (2019).
5. Exposure to bacterial endotoxin generates a distinct strain of α-synuclein fibril. Scientific Reports (2016).
6. Bacterial, viral, and fungal infection‐related risk of Parkinson's disease: Meta‐analysis of cohort and case–control studies. Brain and Behavior (2020).